Seegene Opens New Subsidiary in Bogot?, Colombia, to Advance Regional COVID-19 Testing
November 15, 2021 at 06:00 am EST
Share
Seegene Inc. announced the opening of an eighth global subsidiary, strategically located in Bogot?, Colombia. The new entity, known as 'Seegene Colombia S.A.S,' began operations in mid-October. While the immediate need is for more rapid and accessible COVID-19 testing throughout the region, the subsidiary will also support screening for other viruses such as human papillomaviruses (HPVs). Seegene has seven other subsidiaries in the U.S.A., Canada, Germany, Italy, Mexico, Brazil, and the Middle East, which work closely with the company's headquarters in Seoul, South Korea.
Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The Company provides its products under the brand names of Seeplex, Anyplex and Magicplex. The Company distributes its products within domestic market and to overseas markets.
SEEGENE, INC. 
